Etoricoxib in-situ gel and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 深圳前海九华国际投资控股有限公司
- Publication Date
- 2021-06-01
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The application belongs to the technical field of medicine, and in particular relates to an etoricoxib powder in-situ gel and a preparation method thereof. Background technique
[0002] Etoricoxib (etoricoxib), a selective cyclooxygenase-2 inhibitor, has anti-inflammatory, analgesic and antipyretic effects, used for the treatment of acute and chronic osteoarthritis, and can also be used for the treatment of acute gouty arthritis. Etoricoxib, as a COX-2 (cyclooxygenase-2) inhibitor, compared with traditional non-steroidal anti-inflammatory drugs (NSAIDS), the former can make the occurrence of gastrointestinal peptic ulcer, perforation, bleeding The risk is reduced, and there is no sulfonamide group, which has higher safety for patients with sulfa allergy. Etoricoxib significantly reduced common adverse reactions of non-steroidal anti-inflammatory drugs (NSAIDs), including gastrointestinal mucosal damage, liver and kidney toxicity, allergic reactions, ...